Atlas Trials

Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)

Clinical trial NCT02000050 · COMPLETED

Trial details

NCT number
NCT02000050
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Carcinoma
Start date
2013-10-11
Primary completion
2019-03-15
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.